Table 2.
Efficacy of the two treatments in controlling blood pressure among preeclampsia patients.
Primary endpoints | NIFE + RESV (n = 174) | NIFE + placebo (n = 175) | P value |
---|---|---|---|
Time to control blood pressure (min) | 35.6 ± 18.7 | 51.1 ± 22.4 | 0.01 |
Time before a new hypertensive crisis (h) | 8.0 ± 2.1 | 5.5 ± 1.8 | 0.02 |
NIFE, nifedipine; RESV, resveratrol.